PERITONEAL CANCER
Clinical trials for PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common aspirin may help immune system fight cancer
Disease control Recruiting nowThis early-stage study is testing if adding aspirin to standard chemotherapy helps the body's immune system better fight ovarian, fallopian tube, or peritoneal cancer. It will involve 100 adults who are scheduled for chemotherapy before surgery. Researchers will measure changes i…
Matched conditions: PERITONEAL CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New 'Smart Bomb' drug combo aims to extend remission for ovarian cancer
Disease control Recruiting nowThis study is for women whose ovarian cancer has returned but responded well to a second round of platinum chemotherapy. It tests if adding a newer, targeted drug (mirvetuximab soravtansine) to a standard maintenance drug (bevacizumab) can keep the cancer controlled longer and pr…
Matched conditions: PERITONEAL CANCER
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New combo therapy aims to keep aggressive ovarian cancer at bay
Disease control Recruiting nowThis study is testing whether a combination of two drugs, mirvetuximab soravtansine and olaparib, can help keep cancer from growing back in women whose ovarian, peritoneal, or fallopian tube cancer has returned but initially responded well to platinum-based chemotherapy. The main…
Matched conditions: PERITONEAL CANCER
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Major trial tests powerful drug combo to keep ovarian cancer at bay
Disease control Recruiting nowThis large international study is testing which treatment strategy works better to control advanced ovarian, fallopian tube, or peritoneal cancer after initial chemotherapy. It compares taking the drug niraparib alone versus taking niraparib plus another drug called bevacizumab. …
Matched conditions: PERITONEAL CANCER
Phase: PHASE3 • Sponsor: AGO Study Group • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Blood-Saving technique could transform ovarian cancer surgery
Disease control Recruiting nowThis study is testing whether a blood conservation technique called acute normovolemic hemodilution (ANH) can reduce the need for donor blood transfusions during ovarian cancer surgery. Researchers will randomly assign 86 patients undergoing surgery for advanced ovarian cancer to…
Matched conditions: PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 09, 2026 14:27 UTC
-
Virtual reality goggles could offer Drug-Free relief for cancer pain
Symptom relief Recruiting nowThis study is testing whether virtual reality (VR) can help reduce pain and improve quality of life for people with gastrointestinal cancers. Researchers will compare three approaches: VR that teaches pain management skills, VR designed to distract from pain, and a basic VR contr…
Matched conditions: PERITONEAL CANCER
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Scientists track 371 patients to unlock secrets of ovarian cancer survival
Knowledge-focused Recruiting nowThis study aims to identify what factors are linked to how long patients live after being diagnosed with advanced ovarian, fallopian tube, or peritoneal cancer. It will observe 371 patients over several years, collecting detailed health information and quality of life surveys. Th…
Matched conditions: PERITONEAL CANCER
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC